Artificial intelligence, gradually being integrated into every part of our lives, will soon do just that for our health seems crucial. Because scientists who continue their work within Genetika+, an Israel-based health technology company, personalized medicine with artificial intelligence began to develop.

Scientists started producing brain cells with blood from the patient and worked on it. In the context of the investigations, to antidepressants Focusing experts tested the effects of various drugs on brain cells. By processing all the findings obtained in specially trained artificial intelligence, scientists were able to adjust the correct drug and dosage. Commenting on the topic, Dr. Talia Cohen Solal”The right medicine for every patient instantly we can design.He explained how effective the new method was.

The launch is planned for next year

Funded by the European Research Council of the European Union and the European Innovation Council, the company also collaborates with pharmaceutical companies. If the technology, which is still in development, can show enough success from next year will be placed on the market. Many experts believe that such technology could rewrite the rules of the pharmaceutical industry. In addition, the technology, which for now only focuses on antidepressants, will be used for every disease in the coming years. customizable.

In the meantime; Genetika+ is not the only company producing artificial intelligence-focused drugs. Studies on drugs developed using artificial intelligence models from around the world continue. Even in lung diseases One of the drugs used has been clinically tested for some time. Experts say that while a drug developed using traditional methods takes 4 years, artificial intelligence 18 months They say it can be done in such a short time. In addition, the preference for artificial intelligence in drug production significantly reduces costs.